0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
EV-Based Liquid Biopsy Market by Product Type (Instruments And Platforms, Kits And Reagents, Services), Technology (ELISA, Flow Cytometry, Microarray), Application, Disease Indication, End User - Global Forecast 2025-2030- Product Image
EV-Based Liquid Biopsy Market by Product Type (Instruments And Platforms, Kits And Reagents, Services), Technology (ELISA, Flow Cytometry, Microarray), Application, Disease Indication, End User - Global Forecast 2025-2030- Product Image
Sale

EV-Based Liquid Biopsy Market by Product Type (Instruments And Platforms, Kits And Reagents, Services), Technology (ELISA, Flow Cytometry, Microarray), Application, Disease Indication, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924680
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Extracellular vesicle-based liquid biopsy is enabling new possibilities in noninvasive diagnostics and precision medicine for healthcare and life sciences organizations. This innovative approach offers actionable biomarker insights from minimally invasive samples, supporting informed clinical and strategic decisions within dynamic market conditions.

Market Snapshot: EV-Based Liquid Biopsy Market Overview

The EV-Based Liquid Biopsy Market is exhibiting strong momentum, advancing from USD 473.12 million in 2024 to USD 550.93 million in 2025. Projected to sustain a compound annual growth rate (CAGR) of 15.99%, the market is set to reach USD 1.15 billion by 2030. This expansion reflects increasing adoption in oncology and broader clinical settings, as decision-makers prioritize real-time, noninvasive molecular diagnostics to enhance patient outcomes and operational efficiency.

Scope & Segmentation of the EV-Based Liquid Biopsy Market

  • Product Types: Instruments and platforms such as flow cytometers, NGS platforms, and qPCR instruments; Kits and reagents including detection kits, isolation kits, and labeling reagents; and Services covering analytical and sample preparation functions.
  • Technologies: ELISA, flow cytometry, microarray, nanoparticle assays, next-generation sequencing (NGS), and qPCR protocols that refine biomarker detection.
  • Applications: Companion diagnostics, early cancer detection, prognosis and monitoring, and foundational research into disease mechanisms.
  • Disease Indications: Focus on breast, colorectal, lung, and prostate cancers, driving diverse clinical requirements.
  • End Users: Diagnostic laboratories, hospitals and clinics, pharmaceutical companies, and academic research centers.
  • Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina, and major U.S. states); Europe, Middle East & Africa (with specific focus on the United Kingdom, Germany, France, Russia, Italy, Spain, and others); Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, and additional countries).
  • Leading Companies: Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Techne Corporation, Miltenyi Biotec GmbH, Takara Bio Inc., NanoView Biosciences, HansaBioMed Life Sciences, Norgen Biotek, System Biosciences, and BioVision, Inc.

Key Takeaways for Senior Decision-Makers

  • The evolution of extracellular vesicle-based liquid biopsy is bridging the gap between advanced laboratory research and practical clinical application, offering a scalable route for integrating precision diagnostics.
  • Emerging microfluidic enrichment and high-throughput sequencing are elevating assay sensitivity and enriching the portfolio of detectable cancer biomarkers for early intervention strategies.
  • Strong cross-sector partnerships and regulatory collaborations are accelerating the translation of research innovations into established clinical pathways and commercial workflows.
  • Technological convergence with next-generation sequencing, qPCR, and novel detection kits is supporting versatile, high-confidence data integration into both routine diagnostics and pharmaceutical development pipelines.
  • Standardization initiatives, data sharing, and quality benchmarking are addressing reproducibility concerns, supporting the reliability and acceptance of these platforms across global networks.
  • Competing firms are differentiating through collaborative alliances, proprietary assay platforms, and the development of modular automated solutions adapted to varying resource levels and regulatory requirements.

Tariff Impact on the EV-Based Liquid Biopsy Value Chain

Recent United States tariff adjustments on imported reagents and instrument components are increasing operational costs and supply chain complexity for market participants. In response, manufacturers are focusing on qualifying domestic suppliers and developing regional manufacturing hubs, while laboratories are adopting cost-containment measures and expanding strategic inventory partnerships. These adjustments are strengthening supply chain resilience and sustaining access to critical technologies despite shifts in trade policy.

Methodology & Data Sources

This report adopts a blended research design, integrating in-depth interviews with key opinion leaders, laboratory directors, and technology developers. Primary perspectives are complemented by surveys conducted with stakeholders across healthcare and life sciences sectors. Secondary research comprises detailed reviews of peer-reviewed literature, patent activity, regulatory filings, and corporate disclosures. Data triangulation and expert feedback ensure robust, actionable findings aligned with evolving market realities.

Why This Report Matters for Stakeholders

  • Enables strategic planning by identifying growth areas, product opportunities, and regulatory considerations across all market segments.
  • Guides investment in clinical validation, supply chain resilience, and technology selection for streamlined diagnostic adoption and future-proof scaling.
  • Supports collaboration by uncovering trends in standardization, partnership models, and cross-border innovations relevant to expanding precision medicine initiatives.

Conclusion

Extracellular vesicle-based liquid biopsy is redefining precision diagnostics through its capacity for noninvasive, real-time molecular insights. Strategic adaptation and collaboration are central to navigating regulatory, operational, and technological shifts. This report offers the clarity and segmentation detail needed to support informed decisions in a rapidly advancing market landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms with extracellular vesicle proteomic profiles to improve early cancer detection
5.2. Development of multiplexed microfluidic platforms for high-throughput isolation and analysis of extracellular vesicle subpopulations
5.3. Emergence of standardized protocols for extracellular vesicle isolation and characterization in liquid biopsy workflows in academic and clinical settings
5.4. Application of droplet digital PCR for ultra-sensitive detection of tumor-derived EV RNA biomarkers in plasma specimens
5.5. Collaborations between biotechnology startups and academic centers to accelerate EV biomarker validation for neurodegenerative disease diagnostics
5.6. Regulatory approval pathways and reimbursement strategies shaping clinical adoption of extracellular vesicle based diagnostics in oncology
5.7. Integration of single vesicle analysis techniques to unravel cargo heterogeneity for prognostic and therapeutic response assessments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. EV-Based Liquid Biopsy Market, by Product Type
8.1. Introduction
8.2. Instruments And Platforms
8.2.1. Flow Cytometers
8.2.2. NGS Platforms
8.2.3. qPCR Instruments
8.3. Kits And Reagents
8.3.1. Detection Kits
8.3.2. Isolation Kits
8.3.3. Labeling Reagents
8.4. Services
8.4.1. Analytical Services
8.4.2. Sample Preparation Services
9. EV-Based Liquid Biopsy Market, by Technology
9.1. Introduction
9.2. ELISA
9.3. Flow Cytometry
9.4. Microarray
9.5. Nanoparticle Assays
9.6. NGS
9.7. qPCR
10. EV-Based Liquid Biopsy Market, by Application
10.1. Introduction
10.2. Companion Diagnostics
10.3. Early Cancer Detection
10.4. Prognosis And Monitoring
10.5. Research
11. EV-Based Liquid Biopsy Market, by Disease Indication
11.1. Introduction
11.2. Breast Cancer
11.3. Colorectal Cancer
11.4. Lung Cancer
11.5. Prostate Cancer
12. EV-Based Liquid Biopsy Market, by End User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Hospitals And Clinics
12.4. Pharmaceutical Companies
12.5. Research Centers
13. Americas EV-Based Liquid Biopsy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa EV-Based Liquid Biopsy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific EV-Based Liquid Biopsy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. QIAGEN N.V.
16.3.3. Bio-Techne Corporation
16.3.4. Miltenyi Biotec GmbH
16.3.5. Takara Bio Inc.
16.3.6. NanoView Biosciences, Inc.
16.3.7. HansaBioMed Life Sciences Ltd.
16.3.8. Norgen Biotek Corp.
16.3.9. System Biosciences LLC
16.3.10. BioVision, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EV-BASED LIQUID BIOPSY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. EV-BASED LIQUID BIOPSY MARKET: RESEARCHAI
FIGURE 26. EV-BASED LIQUID BIOPSY MARKET: RESEARCHSTATISTICS
FIGURE 27. EV-BASED LIQUID BIOPSY MARKET: RESEARCHCONTACTS
FIGURE 28. EV-BASED LIQUID BIOPSY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EV-BASED LIQUID BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DETECTION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ISOLATION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ISOLATION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NANOPARTICLE ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NANOPARTICLE ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROGNOSIS AND MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROGNOSIS AND MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 122. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 123. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 124. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 125. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 126. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 127. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 142. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 143. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 220. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 221. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 222. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 223. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 224. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 225. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 236. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 237. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 238. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 239. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 240. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 241. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 246. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 247. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 268. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 269. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 270. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 271. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 272. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 273. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 278. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 279. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 284. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 285. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 286. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 287. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 288. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 289. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 290. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 291. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 294. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 295. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATIO

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

The major companies profiled in this EV-Based Liquid Biopsy market report include:
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Bio-Techne Corporation
  • Miltenyi Biotec GmbH
  • Takara Bio Inc.
  • NanoView Biosciences, Inc.
  • HansaBioMed Life Sciences Ltd.
  • Norgen Biotek Corp.
  • System Biosciences LLC
  • BioVision, Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 550.93 Million
Forecasted Market Value ( USD ) by 2030 $ 1150 Million
Compound Annual Growth Rate15.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Breast Cancer Liquid Biopsy Global Market Report 2025 - Product Image

Breast Cancer Liquid Biopsy Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Liquid Biopsy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Liquid Biopsy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
EUR$4,241USDGBP
Breast Cancer Liquid Biopsy Testing Devices Market by Technology, Application, End User, Test Type, Sample Type, Indication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market by Technology, Application, End User, Test Type, Sample Type, Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Breast Cancer Liquid Biopsy - Global Strategic Business Report - Product Image

Breast Cancer Liquid Biopsy - Global Strategic Business Report

  • Report
  • 217 Pages
  • Global
From
EUR$5,850USDGBP
Breast Cancer Liquid Biopsy Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
EUR$4,500USDGBP

About the EV Based Liquid Biopsy Market

The EV Based Liquid Biopsy market is a rapidly growing segment of the pharmaceutical industry. It is a type of non-invasive diagnostic test that uses circulating cell-free extracellular vesicles (EVs) to detect and monitor cancer. EVs are released from cells into the bloodstream and can be used to detect cancer-specific biomarkers, providing a more accurate diagnosis than traditional methods. This technology has the potential to revolutionize cancer diagnosis and treatment, as it can detect cancer at an earlier stage and provide more precise information about the disease. EV Based Liquid Biopsy is also being used to monitor the effectiveness of cancer treatments, as well as to detect and monitor other diseases such as cardiovascular disease and neurological disorders. This technology is being used in clinical trials and is expected to become more widely available in the near future. Some companies in the EV Based Liquid Biopsy market include Exosome Diagnostics, Exosomics, Exosome Sciences, and Exosome Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more